Status:

NOT_YET_RECRUITING

The Alternative Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia

Lead Sponsor:

Yuanyuan Wu

Collaborating Sponsors:

Pingyang County Traditional Chinese Medicine Hospital

Jiaxing Traditional Chinese Medicine Hospital

Conditions:

Trigeminal Neuralgia

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Trigeminal neuralgia (TN), characterized by its refractory nature and recurrence, frequently leads to anxiety, depression, and insomnia, thereby significantly diminishing patients' quality of life and...

Detailed Description

This study will enroll a total of 148 patients with TN who meet the inclusion criteria. Participants will be randomized in a 1:1 ratio to either the EA plus placebo group or the sham EA plus CBZ group...

Eligibility Criteria

Inclusion

  • Participants must meet all of the following criteria to be eligible for this study
  • Met the diagnostic criteria for trigeminal neuralgia (TN) as defined in the International Classification of Headache Disorders, 3rd edition (ICHD-3) published by the International Headache Society (IHS) in 2018.
  • Between 18 and 75 years old (inclusive), regardless of gender;
  • Currently prescribed carbamazepine (100-300 mg/day) or oxcarbazepine (200-600 mg/day);
  • Conscious, alert, and capable of perceiving/differentiating pain, with basic communication abilities;
  • Signed informed consent form and voluntary participation in the study.

Exclusion

  • Patients meeting any of the following criteria were excluded
  • Patients with epilepsy, head injury, or other relevant neurological disorders;
  • Patients with severe cardiac, hepatic, or renal impairment;
  • Patients with cognitive dysfunction, aphasia, psychiatric disorders, or those unable to cooperate with treatment;
  • Patients with poorly controlled hypertension or hyperglycemia;
  • Patients with a recent diagnosis of severe anxiety or depression;
  • Pregnant or breastfeeding patients;

Key Trial Info

Start Date :

May 20 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

148 Patients enrolled

Trial Details

Trial ID

NCT06977932

Start Date

May 20 2025

End Date

December 31 2028

Last Update

May 18 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.